Innovative Research Award
Koteswara Rao Yerra
Texas A&M University, United States
Koteswara Rao Yerra is a researcher affiliated with Texas A&M University whose scholarly record reflects sustained activity in medicine and health sciences. Available bibliometric information reports 90 documents, 4,645 citations, and an h-index of 41, providing a quantitative basis for assessing research visibility and influence. [1]
Abstract
The Innovative Research Award profile recognizes a research trajectory characterized by publication activity, citation visibility, and investigation of clinically relevant biomedical questions. Recent work associated with this profile examines antimicrobial photodynamic therapy, antibiotic enhancement, photosensitizer combinations, inflammatory mechanisms, and oxidative stress. These studies demonstrate an interdisciplinary orientation connecting microbiology, pharmacology, infection research, and therapeutic development.
Keywords
Antimicrobial photodynamic therapy; Klebsiella pneumoniae; antibiotics; photosensitizers; inflammation; oxidative stress; NLRP3 inflammasome; biomedical research; infection therapeutics.
Introduction
Contemporary infection research increasingly explores therapeutic strategies that can complement conventional antibiotics. Photodynamic approaches are particularly relevant because they investigate how light-activated photosensitizers may contribute to antimicrobial activity. Recent publications in this research portfolio address these questions using experimental models involving Klebsiella pneumoniae and inflammatory responses. [2]
Research Profile
The reported Scopus record comprises 90 documents and 4,645 citations, with an h-index of 41. [1] The subject classification of Medicine and Health Sciences provides a broad disciplinary context for work spanning antimicrobial strategies and host inflammatory mechanisms. The ORCID identifier 0000-0001-6063-904X provides an additional persistent researcher identifier. [5]
Research Contributions
Recent contributions include investigation of dual-photosensitizer antimicrobial photodynamic therapy combined with antibiotics against Klebsiella pneumoniae, published in Pharmaceutics in May 2026. [2] Related work evaluates methylene blue and photodithazine combinations and examines photodynamic enhancement of antibiotic effects. [3] Another study investigates cinnamaldehyde, oxidative stress, and NLRP3 inflammasome-related inflammatory responses in infected macrophages. [4]
Publications
- Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics — Pharmaceutics, 2026; [2]
- Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response by reducing oxidative stress in Neisseria gonorrhoeae-infected macrophages — Journal of Traditional and Complementary Medicine, 2026. [4]
- The Combined Photosensitizers in Antimicrobial Photodynamic Therapy — International Journal of Molecular Sciences, 2025. [3]
- Enhancing Antibiotic Effect by Photodynamic: The Case of Klebsiella pneumoniae — Antibiotics, 2025. [6]
Research Impact
The combination of substantial citation activity and a broad publication record provides measurable evidence of scholarly reach. The reported h-index of 41 indicates that a considerable portion of the indexed publication portfolio has accumulated repeated citation impact. [1] Recent publications also indicate continued engagement with antimicrobial resistance, photodynamic therapeutics, and molecular mechanisms of infection.
Award Suitability
The documented research profile is relevant to an Innovative Research Award because it combines established bibliometric activity with recent investigations addressing therapeutic challenges. The work on photodynamic treatment and antibiotic combinations is particularly aligned with innovation in biomedical research, while studies of inflammatory pathways contribute mechanistic perspectives to infectious-disease research.
Conclusion
Koteswara Rao Yerra’s documented scholarly profile presents a sustained contribution to Medicine and Health Sciences, supported by 90 documents, 4,645 citations, and an h-index of 41. Recent research extending photodynamic antimicrobial strategies and investigating inflammation-related mechanisms further demonstrates continued scientific activity in clinically relevant areas. [1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Koteswara Rao Yerra, Author ID 7201581139. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7201581139
- MDPI. (2026). Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics: A New Investigation Modality Against Klebsiella pneumoniae. Pharmaceutics, 18(5), 587.
https://doi.org/10.3390/pharmaceutics18050587
- MDPI. (2025). The Combined Photosensitizers in Antimicrobial Photodynamic Therapy: The Case of Methylene Blue and Photodithazine Against Klebsiella pneumoniae. International Journal of Molecular Sciences, 26(20), 10211.
https://doi.org/10.3390/ijms262010211
- Journal of Traditional and Complementary Medicine. (2026). Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response by reducing oxidative stress in Neisseria gonorrhoeae-infected macrophages.
https://doi.org/10.1016/J.JTCME.2025.06.003
- ORCID. (n.d.). Koteswara Rao Yerra — ORCID record.
https://orcid.org/0000-0001-6063-904X
- MDPI. (2025). Enhancing Antibiotic Effect by Photodynamic: The Case of Klebsiella pneumoniae. Antibiotics. https://doi.org/10.3390/antibiotics14080766